Product Information

ARMODAFINIL 250 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.9472 per EA under NDC 00378343393. Its NADAC has been published 510 times since Sep 21, 2016.

ARMODAFINIL 250 MG TABLET

armodafinil
$0.9472per EA
DEA Schedule CIV

Strength

250 mg/1

NDC

00378343393

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

ARMODAFINIL

Approval Type

Generic (ANDA)

FDA Application

ANDA200043

On Market Since

6/1/2016

Price Statistics

The NADAC for ARMODAFINIL 250 MG TABLET has been published 510 times since Sep 21, 2016, and over the history we have for it it has declined 94.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.9472 per EA
All-time high$17.3931 (Dec 14, 2016)
All-time low$0.6325 (Nov 20, 2024)
52-week high$0.9673
52-week low$0.8346
Median price$1.0657
Average price$1.7770
Largest weekly change-86.6% (Feb 22, 2017)
Weeks tracked510
Tracking sinceSep 21, 2016

Price History

1W

0.0%

1M

+1.8%

3M

+1.9%

6M

-1.5%

1Y

+12.5%

3Y

+20.7%

5Y

-26.0%

All

-94.5%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the armodafinil market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of ARMODAFINIL 250 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ARMODAFINIL 250 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.9472 per EA (NDC 00378343393), effective Jun 24, 2026.

How has the price of ARMODAFINIL 250 MG TABLET changed over time?

Over the history we have for it, the NADAC for ARMODAFINIL 250 MG TABLET has declined 94.5%. It has been tracked across 510 weekly CMS publications since Sep 21, 2016.

What are the highest and lowest recorded NADAC prices for ARMODAFINIL 250 MG TABLET?

Since Sep 21, 2016, the NADAC for ARMODAFINIL 250 MG TABLET has ranged from a low of $0.6325 (Nov 20, 2024) to a high of $17.3931 (Dec 14, 2016), with a median of $1.0657 per EA.

Are there cheaper alternatives to ARMODAFINIL 250 MG TABLET?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ARMODAFINIL 250 MG TABLET, so no direct lower-cost alternative is listed.

Who manufactures ARMODAFINIL 250 MG TABLET?

ARMODAFINIL 250 MG TABLET (NDC 00378343393) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.

Related Drugs

Same classification

No related drugs found.